China
China's licensing boom reshapes global pharma power
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
Why China's pharma market is now a consumer game
Stakeholders must understand this moment, as it signifies a fundamental shift in the industry.
China’s pharma growth shifts from drugs to high-tech manufacturing
However, there is still a lot of pressure in pharmaceutical manufacturing.
Raffles Medical, Chongqing Hospital to form new collaboration model
A key partnership area includes the development of a medical consortium.
Healthcare improvements drive China’s oxygenators market
The country is expected to maintain a 50% market share in APAC through 2025.
Most Read
1. NHG Health unveils Serangoon Polyclinic in Singapore 2. Chang Gung Hospital targets bigger Philippine patient base 3. Medical membranes market to be valued at $6.66b by 2030 4. 7MM autism spectrum disorder market to be valued at $2b by 2034 5. Apollo Hospitals and Coal India sign MoU to expand healthcare accessResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
